|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Research and development expenses, net | |||||
| Selling, general and administrative expenses | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest expense | |||||
| Gain on revaluation of contingent earn-out liability | |||||
| Interest income | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Loss per share: Basic | |||||
| Loss per share: fully diluted | |||||
| Weighted average common shares outstanding: Basic | |||||
| Weighted average common shares outstanding: fully diluted | |||||
Loading...